Point72 Hong Kong’s Edgewise Therapeutics EWTX Stock Holding History

Point72 Hong Kong’s Portfolio EWTX Stock Details EWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-576	Closed	-$6K	–	608
2022 Q3	$6K	Buy	+576	New	+$5.82K	﹤0.01%	1776

Other funds holding EWTX

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Hong Kong's EWTX Position: Q4 2022 in Review

Point72 Hong Kong sold out of Edgewise Therapeutics (EWTX) in Q4 2022, closing a stake of 576 shares — an estimated $6K sold.

Point72 Hong Kong first reported a position in EWTX in Q3 2022 and held it in 1 quarter. The position peaked at $6K in Q3 2022. 90 funds tracked by Wall St. Rank hold EWTX as of Q4 2022.

Point72 Hong Kong reported no remaining Edgewise Therapeutics position as of Q4 2022 after selling out during the quarter.
Point72 Hong Kong sold 576 Edgewise Therapeutics shares in Q4 2022, an estimated $6K.
Point72 Hong Kong first reported a position in Edgewise Therapeutics in Q3 2022 and held it in 1 quarter.
Point72 Hong Kong's Edgewise Therapeutics position peaked at $6K in Q3 2022.
90 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.